Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Share News (DVO)

  • There is currently no data for DVO

Non-execs show confidence in Devro

Tue, 22nd Feb 2011 16:53
Buying by Devro directors has kept the share price rising after yesterday's annual results from the sausage casings manufacturer. The shares rose a further 9% to 265.1p each. Chairman Steve Hannam bought 16,616 shares at 240p each, taking his stake to 149,306. The total investment was nearly £39,000. Hannam has been chairman since May 2009. Non-executive director Paul Neep acquired 6,070 shares at 241p each, which cost £14,629. He owns 193,593 shares in Devro. Neep, who is chief executive of LVMH subsidiary Glenmorangie, has been on the board since 2005. Devro's profit before tax and exceptional items in 2010 rose 44% to £36.3m. Reported profit before tax doubled to £55.2m from £26.9m, as 2010's results benefited from an £18.9m exceptional credit derived from a reduction in the liabilities of the group's UK defined benefit pension scheme. Operating margin improved to 16.1% from 12.4%, reflecting higher prices and a more efficient manufacturing cost base.Panmure Gordon raised its 2011 profit forecast after the figures. The earnings per share forecast was increased from 18.1p to 19.5p. Top Director BuysDevro (DVO) Director name: Mr Steve HannamAmount purchased: 16,616 @ 240.00pValue: £39,878Devro (DVO) Director name: Mr Paul NeepAmount purchased: 6,070 @ 241.00Value: £14,629Top Director SellsCarnival (CCL) Director name: Mr Peter RatcliffeAmount sold: 22,909 @ 2,838.95p Value: £650,375Carnival (CCL) Director name: Mr Pier Luigi FoschiAmount sold: 16,593 @ 2,838.95p Value: £471,067GlaxoSmithKline (GSK) Director name: Mr Simon BicknellAmount sold: 1,286 @ 1,201.00p Value: £15,445Europa Oil & Gas (EOG) Director name: Mr Paul A BarrettAmount sold: 25,000 @ 41.64p Value: £10,410Europa Oil & Gas (EOG) Director name: Mr Paul A BarrettAmount sold: 25,000 @ 41.62p Value: £10,405

Related News

IN BRIEF: GSK executives, including non-exec chair, buy shares
4 hours ago

IN BRIEF: GSK executives, including non-exec chair, buy shares

GSK PLC - London-based pharmaceuticals firm - Non-Executive Chair Jonathan Symonds buys 1,550 shares at GBP19.35 for total GBP29,992.50 last Friday. D...

TRADING UPDATES: Maintel fundraising completes; ValiRx ends deal
1 day ago

TRADING UPDATES: Maintel fundraising completes; ValiRx ends deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

DVO.L News

Tuesday broker round-up UPDATE
5 Aug 2014

Tuesday broker round-up UPDATE

Acal: FinnCap initiates with a target price of 322p and a buy recommendation. Afren: UBS reduces target price from 200p to 135p and stays with its bu...

Monday broker round-up UPDATE
4 Aug 2014

Monday broker round-up UPDATE

Afren: Canaccord Genuity reinstates with a target price of 120p and a hold recommendation. Bodycote: N+1 Singer cuts target price from 850p to 835p, ...

Astrazeneca chairman add 6,000 shares
1 Aug 2014

Astrazeneca chairman add 6,000 shares

Improved full year guidance ensured Astrazeneca shares proved popular with board members this week, with chairman Leif Johansson adding a further 6,00...